RxDoctor Payments Data

Nathan Aranson, MD

Vascular Surgery · S Portland, MENPI 1497915847

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Silk Road Medical, Inc. at 59.5% of the total. Among vascular surgery clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$459,682in general payments, 2019–2025

Across 724 payments — averaging $634.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$274K
  • Boston Scientific$84K
  • Shockwave Medical, Inc$72K
  • Medtronic$15K
  • Penumbra, Inc.$3K
  • W. L. Gore & Associates, Inc.$2K
  • plus $10K from 23 others
$95,768in research payments, 2019–2025

Across 8 payments — averaging $11,971 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Philips North America LLC$85K
  • Silk Road Medical, Inc.$10K

What the payments were for

  • Consulting fees$238,78852%
  • Speaking & faculty fees$121,05026%
  • Travel & lodging$72,11316%
  • Food & beverage$27,7326%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$459,682 in reported general payments places this provider in the 95th percentile of 30 vascular surgery providers in Maine.

See all vascular surgery providers in Maine

Medicare billing

Part B allowed, 2024
$228,371
Medicare patients
169
Services billed
678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol27$506
ClopidogrelClopidogrel Bisulfate27$223
Oxycodone Hcl19$74

Paid to pharmacies, not to this prescriber.

Other vascular surgery in S Portland

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →